U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C27H30O6
Molecular Weight 450.5235
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of SOFALCONE

SMILES

CC(C)=CCOC1=CC=C(\C=C\C(=O)C2=CC=C(OCC=C(C)C)C=C2OCC(O)=O)C=C1

InChI

InChIKey=GFWRVVCDTLRWPK-KPKJPENVSA-N
InChI=1S/C27H30O6/c1-19(2)13-15-31-22-8-5-21(6-9-22)7-12-25(28)24-11-10-23(32-16-14-20(3)4)17-26(24)33-18-27(29)30/h5-14,17H,15-16,18H2,1-4H3,(H,29,30)/b12-7+

HIDE SMILES / InChI

Molecular Formula C27H30O6
Molecular Weight 450.5235
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Description

Sofalcone is a mucosal protective agent that has been reported to inhibit growth of Helicobacter pylori. It is considered safe and effective for the treatment of gastritis and gastric ulcer. It is used in Japan. Adverse reactions are: liver dysfunction, jaundice, rash, constipation, dry mouth, heartburn.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Solon
Primary
Solon

Cmax

ValueDoseCo-administeredAnalytePopulation
0.39 μg/mL
50 mg single, oral
SOFALCONE plasma
Homo sapiens
1.27 μg/mL
100 mg single, oral
SOLFACONE plasma
Homo sapiens
2.11 μg/mL
200 mg single, oral
SOLFACONE plasma
Homo sapiens

AUC

ValueDoseCo-administeredAnalytePopulation
1.26 μg × h/mL
50 mg single, oral
SOFALCONE plasma
Homo sapiens
3.99 μg × h/mL
100 mg single, oral
SOLFACONE plasma
Homo sapiens
5.48 μg × h/mL
200 mg single, oral
SOLFACONE plasma
Homo sapiens

T1/2

ValueDoseCo-administeredAnalytePopulation
3.29 h
50 mg single, oral
SOFALCONE plasma
Homo sapiens
2.77 h
100 mg single, oral
SOLFACONE plasma
Homo sapiens
3.38 h
200 mg single, oral
SOLFACONE plasma
Homo sapiens

Doses

AEs

PubMed

Sample Use Guides

In Vivo Use Guide
Adults take 100 mg of sofalcone 3 times a day.
Route of Administration: Oral
In Vitro Use Guide
MIC50 for Helicobacter pylori is 12.5 ug/ml
Substance Class Chemical
Record UNII
2B668TJX8E
Record Status Validated (UNII)
Record Version